Cita APA (7a ed.)

E, C., E, B., E, R., O, Z., J, E., O, L., & S, M. (2017). Sitagliptin ameliorates oxidative stress in experimental diabetic nephropathy by diminishing the miR-200a/Keap-1/Nrf2 antioxidant pathway. Dove Medical Press.

Cita Chicago Style (17a ed.)

E, Civantos, Bosch E, Ramirez E, Zhenyukh O, Egido J, Lorenzo O, y Mas S. Sitagliptin Ameliorates Oxidative Stress in Experimental Diabetic Nephropathy by Diminishing the MiR-200a/Keap-1/Nrf2 Antioxidant Pathway. Dove Medical Press, 2017.

Cita MLA (8a ed.)

E, Civantos, et al. Sitagliptin Ameliorates Oxidative Stress in Experimental Diabetic Nephropathy by Diminishing the MiR-200a/Keap-1/Nrf2 Antioxidant Pathway. Dove Medical Press, 2017.